已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers

纳米载体 化学 内吞作用 固体脂质纳米粒 脂质体 药物输送 毒品携带者 并行传输 脂质双层 跨细胞 生物化学 脂类消化 酶 膜 脂肪酶 受体 有机化学 磁导率
作者
Soheil Haddadzadegan,Farid Abedin Dorkoosh,Andreas Bernkop‐Schnürch
出处
期刊:Advanced Drug Delivery Reviews [Elsevier BV]
卷期号:182: 114097-114097 被引量:434
标识
DOI:10.1016/j.addr.2021.114097
摘要

The oral administration of therapeutic peptides and proteins is favoured from a patient and commercial point of view. In order to reach the systemic circulation after oral administration, these drugs have to overcome numerous barriers including the enzymatic, sulfhydryl, mucus and epithelial barrier. The development of oral formulations for therapeutic peptides and proteins is therefore necessary. Among the most promising formulation approaches are lipid-based nanocarriers such as oil-in-water nanoemulsions, self-emulsifying drug delivery systems (SEDDS), solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC), liposomes and micelles. As the lipophilic character of therapeutic peptides and proteins can be tremendously increased such as by the formation of hydrophobic ion pairs (HIP) with hydrophobic counter ions, they can be incorporated in the lipophilic phase of these carriers. Since gastrointestinal (GI) peptidases as well as sulfhydryl compounds such as glutathione and dietary proteins are too hydrophilic to enter the lipophilic phase of these carriers, the incorporated therapeutic peptide or protein is protected towards enzymatic degradation as well as unintended thiol/disulfide exchange reactions. Stability of lipid-based nanocarriers towards lipases can be provided by the use to excipients that are not or just poorly degraded by these enzymes. Nanocarriers with a size <200 nm and a mucoinert surface such as PEG or zwitterionic surfaces exhibit high mucus permeating properties. Having reached the underlying absorption membrane, lipid-based nanocarriers enable paracellular and lymphatic drug uptake, induce endocytosis and transcytosis or simply fuse with the cell membrane releasing their payload into the systemic circulation. Numerous in vivo studies provide evidence for the potential of these delivery systems. Within this review we provide an overview about the different barriers for oral peptide and protein delivery, highlight the progress made on lipid-based nanocarriers in order to overcome them and discuss strengths and weaknesses of these delivery systems in comparison to other technologies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Huang完成签到 ,获得积分0
2秒前
hugo发布了新的文献求助10
2秒前
奋斗易真发布了新的文献求助10
5秒前
5秒前
没有好果汁吃完成签到 ,获得积分10
5秒前
令狐大侠发布了新的文献求助10
6秒前
令狐大侠发布了新的文献求助10
6秒前
CodeCraft的应助被cheng采纳,获得10
6秒前
令狐大侠发布了新的文献求助10
7秒前
7秒前
7秒前
彭于晏的应助被积极北上采纳,获得10
8秒前
喵了个咪完成签到,获得积分10
8秒前
zz发布了新的文献求助10
8秒前
上官若男的应助被帅气恋风采纳,获得10
8秒前
Anna完成签到,获得积分10
9秒前
令狐大侠发布了新的文献求助10
9秒前
令狐大侠发布了新的文献求助10
9秒前
令狐大侠发布了新的文献求助10
9秒前
1fser1完成签到,获得积分10
9秒前
令狐大侠发布了新的文献求助10
10秒前
11秒前
11秒前
HiJ完成签到,获得积分10
12秒前
zhaoty完成签到,获得积分10
12秒前
13秒前
令狐大侠发布了新的文献求助10
13秒前
令狐大侠发布了新的文献求助10
13秒前
13秒前
小蘑菇的应助被平平采纳,获得10
13秒前
李明洪完成签到,获得积分10
13秒前
令狐大侠发布了新的文献求助10
14秒前
wanci的应助被feihu采纳,获得10
14秒前
洁净山柏发布了新的文献求助10
15秒前
15秒前
令狐大侠发布了新的文献求助10
16秒前
令狐大侠发布了新的文献求助10
16秒前
哈基橙关注了科研通微信公众号
16秒前
16秒前
令狐大侠发布了新的文献求助30
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8179198
求助须知:如何正确求助?哪些是违规求助? 9569781
关于积分的说明 21806509
捐赠科研通 7774542
什么是DOI,文献DOI怎么找? 3433008
关于科研通互助平台的介绍 2556929
邀请新用户注册赠送积分活动 2478652